{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&_metadata=all&hansardHeading=Drugs%3A+Misuse", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "items" : [{"_about" : "http://data.parliament.uk/resources/1680755", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1680755/answer", "answerText" : {"_value" : "

The term \u2018harm reduction units for the use of drug taking in a safe environment\u2019 refers to what are often more commonly known as Drug Consumption Rooms (DCRs).<\/p>

The Government does not support DCRs. We have been clear that we have concerns about the potential for these facilities to appear to condone drug use and to encourage the continued illicit supply of drugs. They will not be introduced in England and Wales. While we remain open to considering any new evidence, the evidence available to date has informed the current policy position.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2024-01-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-01-16T17:42:26.383Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2024-01-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, if he will make an assessment of the potential merits of harm reduction units for the use of drug taking in a safe environment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4471", "label" : {"_value" : "Biography information for Rachael Maskell"} } , "tablingMemberConstituency" : {"_value" : "York Central"} , "tablingMemberPrinted" : [{"_value" : "Rachael Maskell"} ], "uin" : "8775"} , {"_about" : "http://data.parliament.uk/resources/1675121", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1675121/answer", "answerText" : {"_value" : "

BlueLight Commercial is company that is owned by the policing sector. It was set up to provide commercial expertise and assistance to policing and assist forces in identifying and making efficiency savings.<\/p>

The Government have not provided specific funding to BlueLight Commercial for their work on Operation Safeguard. BlueLight Commercial have direct arrangements with the policing sector to cover administrative costs they have incurred for the work they have delivered.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-12-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-12T12:48:43.133Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-12-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, how much funding was provided to Blue Blight Commercial as part of Operation Safeguard.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4389", "label" : {"_value" : "Biography information for Ruth Cadbury"} } , "tablingMemberConstituency" : {"_value" : "Brentford and Isleworth"} , "tablingMemberPrinted" : [{"_value" : "Ruth Cadbury"} ], "uin" : "5061"} , {"_about" : "http://data.parliament.uk/resources/1659479", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1659479/answer", "answerText" : {"_value" : "

The Home Office has undertaken an assessment of the potential impacts of the Misuse of Drugs Act 1971 (Amendment) Order 2023, which will ban nitrous oxide, on the police, courts and prison systems.<\/p>

The impact assessment is published at The Misuse of Drugs Act 1971 (Amendment) Order 2023 - Impact Assessment<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-09-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "198603"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-18T10:28:14.397Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-09-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, what assessment she has made of the potential impact of the Misuse of Drugs Act 1971 (Amendment) Order 2023 on the (a) workload of and (b) resources available to police forces.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/178", "label" : {"_value" : "Biography information for John McDonnell"} } , "tablingMemberConstituency" : {"_value" : "Hayes and Harlington"} , "tablingMemberPrinted" : [{"_value" : "John McDonnell"} ], "uin" : "198588"} , {"_about" : "http://data.parliament.uk/resources/1643600", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1643600/answer", "answerText" : {"_value" : "

In December 2021, the Government published a 10-year drug strategy which committed an additional £532 million of funding over three years for drug and alcohol treatment services. Evaluations assessing the delivery, impact, and value for money of the overall investment as well as specific treatment and recovery programmes will be completed by Autumn 2025.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} , "dateOfAnswer" : {"_value" : "2023-06-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-19T16:01:12.537Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-06-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made on effectiveness of the Additional drug and alcohol treatment funding allocations 2022 to 2023 in supporting universal drug treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4410", "label" : {"_value" : "Biography information for Julian Knight"} } , "tablingMemberConstituency" : {"_value" : "Solihull"} , "tablingMemberPrinted" : [{"_value" : "Julian Knight"} ], "uin" : "188954"} , {"_about" : "http://data.parliament.uk/resources/1643136", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1643136/answer", "answerText" : {"_value" : "

The Home Office has not received an advance draft of the ACMD\u2019s barriers to research \u2013 part 2 report. I look forward to receiving the ACMD\u2019s advice on this important topic.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-06-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-13T14:30:26.67Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-06-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, with reference to Advisory Council on the Misuse of Drugs' Part 2 report on Barriers to Research commission, published 12th December 2022, when her Department received a draft copy of the report; when she expects the final document to be published; and for what reasons her Department received an advance draft copy.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/104", "label" : {"_value" : "Biography information for Crispin Blunt"} } , "tablingMemberConstituency" : {"_value" : "Reigate"} , "tablingMemberPrinted" : [{"_value" : "Crispin Blunt"} ], "uin" : "188448"} , {"_about" : "http://data.parliament.uk/resources/1642216", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1642216/answer", "answerText" : {"_value" : "

As the ACMD is an independent Non-Departmental Public Body (NDPB), sponsored by the Home Office, the timings concerning its report on Barriers to Research is a matter for the ACMD.<\/p>

I expect to receive an update from the ACMD in due course.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-06-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-14T15:49:41.983Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-06-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, when she expects to publish the report by the Advisory Council on the Misuse of Drugs on Part 2 review on barriers to research affecting Schedule 1 drugs; and if she will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1428", "label" : {"_value" : "Biography information for Sir Bill Wiggin"} } , "tablingMemberConstituency" : {"_value" : "North Herefordshire"} , "tablingMemberPrinted" : [{"_value" : "Sir Bill Wiggin"} ], "uin" : "187906"} , {"_about" : "http://data.parliament.uk/resources/1627764", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1627764/answer", "answerText" : {"_value" : "

On 10 May 2023, I commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of synthetic cathinones, currently class B, including those sold under the street name \u2018monkey dust\u2019. I have asked that this assessment includes consideration of whether certain synthetic cathinones are significantly more harmful than others and may therefore merit a separate approach in terms of classification.<\/p>

The Government has a statutory duty to consult the ACMD prior to making any changes to classification under the Misuse of Drugs Act 1971. Once their report is published, I will carefully consider the ACMD\u2019s expert advice to inform the Government\u2019s decision on how best to tackle misuse of these drugs, including the appropriate classification.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-05-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-05-22T15:56:37.117Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-05-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, what steps her Department is taking to review the drug classification of (a) monkey dust and (b) other synthetic cathinones.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4410", "label" : {"_value" : "Biography information for Julian Knight"} } , "tablingMemberConstituency" : {"_value" : "Solihull"} , "tablingMemberPrinted" : [{"_value" : "Julian Knight"} ], "uin" : "185010"} , {"_about" : "http://data.parliament.uk/resources/1606606", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1606606/answer", "answerText" : {"_value" : "

No recent assessment has been made. Assessments are made on a case by case basis as individual drugs or drug harms are identified. Drug Legislation forms part of our wider approach to preventing drug misuse alongside prevention and education, supporting treatment and recovery, and tackling the supply of illicit drugs.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-03-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-28T15:50:47.11Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-03-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, what recent assessment she has made of the impact of the Misuse of Drug Act 1971 on the criminal justice system.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"} } , "tablingMemberConstituency" : {"_value" : "Central Ayrshire"} , "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"} ], "uin" : "904349"} , {"_about" : "http://data.parliament.uk/resources/1606607", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1606607/answer", "answerText" : {"_value" : "

No recent assessment has been made. Assessments are made on a case by case basis as individual drugs or drug harms are identified.<\/p>

Drug Legislation forms part of our wider approach to preventing drug misuse alongside prevention and education, supporting treatment and recovery, and tackling the supply of illicit drugs.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4503", "label" : {"_value" : "Biography information for Chris Philp"} } , "answeringMemberConstituency" : {"_value" : "Croydon South"} , "answeringMemberPrinted" : {"_value" : "Chris Philp"} , "dateOfAnswer" : {"_value" : "2023-03-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-28T15:49:14.973Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-03-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for the Home Department, what recent assessment she has made of the impact of the Misuse of Drug Act 1971 on the criminal justice system.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4424", "label" : {"_value" : "Biography information for John McNally"} } , "tablingMemberConstituency" : {"_value" : "Falkirk"} , "tablingMemberPrinted" : [{"_value" : "John McNally"} ], "uin" : "904357"} , {"_about" : "http://data.parliament.uk/resources/1603513", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1603513/answer", "answerText" : {"_value" : "

The Department of funds research through the National Institute for Health and Care Research (NIHR) and the NIHR welcomes funding applications for research into any aspect of human health, including recreational drugs, it is not usual practice to ring-fence funds for particular topics or conditions. In September 2022, the Department and the Joint Combating Drugs Unit, in partnership with NIHR, launched a £5 million innovation fund to reduce demand for illicit substances. The fund will be run in three phases, phase one will focus on the development of potential interventions, phase two on testing and evaluation of these interventions, and phase three on scale up of interventions that are evaluated as effective in phase two.<\/p>

On 8 March 2023 the Department announced £734,000 funding to support five projects through phase one.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} , "dateOfAnswer" : {"_value" : "2023-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-20T16:51:27.133Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Misuse"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what funding his Department is allocating to support research on how to reduce the use of recreational drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4410", "label" : {"_value" : "Biography information for Julian Knight"} } , "tablingMemberConstituency" : {"_value" : "Solihull"} , "tablingMemberPrinted" : [{"_value" : "Julian Knight"} ], "uin" : "163803"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&legislature.prefLabel=House+of+Commons&min-date=2022-07-21&max-date=2024-01-09&hansardHeading=Drugs%3A+Misuse", "page" : 0, "startIndex" : 1, "totalResults" : 15, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }